{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:19:16Z","timestamp":1787847556172,"version":"build-2784847793"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is highly prevalent in Nigeria and is frequently complicated by sickle cell nephropathy, which often begins with asymptomatic microalbuminuria. Chronic hemolysis leads to nitric oxide depletion and vasculopathy, and L-arginine, its substrate, may serve as a biomarker of disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>To determine the relationship between serum L-arginine levels and microalbuminuria among adolescents and adults with SCD in Kano, Nigeria.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>This comparative cross-sectional study was conducted among patients aged \u226516 years attending hematology clinics of Aminu Kano Teaching Hospital and Murtala Muhammad Specialist Hospital. Participants were screened for microalbuminuria and categorized into microalbuminuria and non-microalbuminuria groups. Serum L-arginine, lactate dehydrogenase, total bilirubin and cystatin C were measured, and estimated glomerular filtration rate was calculated using cystatin-C\u2013based equations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 246 screened patients, microalbuminuria prevalence was 17.5%. Eighty participants were studied (43 with microalbuminuria, 37 controls). Patients with microalbuminuria had significantly lower serum L-arginine levels than controls (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). Markers of hemolysis (LDH and bilirubin) and cystatin C were significantly higher, while eGFR was lower in the microalbuminuria group (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Reduced L-arginine levels are associated with microalbuminuria in SCD and may serve as an early marker of nephropathy. In resource-limited settings, routine microalbuminuria screening, with optional L-arginine assessment, can help identify high-risk patients and guide timely renal-protective interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_853_25","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T01:00:18Z","timestamp":1780016418000},"page":"574-579","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association Between L-Arginine Levels and Microalbuminuria in Sickle Cell Disease: A Cross-Sectional Study in a Tertiary Hospital in Northwest Nigeria"],"prefix":"10.4103","volume":"29","author":[{"given":"DH","family":"Gwarzo","sequence":"first","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kuliya-Gwarzo","sequence":"additional","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Yusuf","sequence":"additional","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SU","family":"Abdullahi","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IM","family":"Idris","sequence":"additional","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YD","family":"Jobbi","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Abdulsalam","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Galadanci","sequence":"additional","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Borodo","sequence":"additional","affiliation":[{"name":"Department of Haematology, Bayero University, Kano, Nigeria"},{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BM","family":"Musa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Babandi","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Federal University Dutse, Jigawa, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Aminu","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Department of Haematology, Murtala Muhammad Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"UA","family":"Makuku","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aminu","sequence":"additional","affiliation":[{"name":"Department of Haematology, Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KA","family":"Ahmed","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IY","family":"Mohammed","sequence":"additional","affiliation":[{"name":"Department of Chemical Pathology, Bayero University\/Aminu Kano Teaching Hospital, Kano, Nigeria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"Suppl 1","key":"R1-20260529","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1182\/blood-2019-131344","article-title":"Advancing healthcare outcomes for sickle cell disease in Nigeria using mobile health tools","volume":"134","author":"Fraiwan","year":"2019","journal-title":"Blood"},{"key":"R2-20260529","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ajh.21475","article-title":"Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions","volume":"84","author":"Kato","year":"2009","journal-title":"Am J Hematol"},{"issue":"5 Pt 1","key":"R3-20260529","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/ajrccm.159.5.9810094","article-title":"The acute chest syndrome in sickle cell disease: Possible role of nitric oxide in its pathophysiology and treatment","volume":"159","author":"Gladwin","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"R4-20260529","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nm1202-799","article-title":"Cell-free haemoglobin limits nitric oxide bioavailability in sickle-cell disease","volume":"8","author":"Reiter","year":"2002","journal-title":"Nat Med"},{"key":"R6-20260529","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4103\/1319-2442.128495","article-title":"An update on sickle cell nephropathy","volume":"25","author":"Alweish","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R7-20260529","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R8-20260529","doi-asserted-by":"crossref","first-page":"e1001484","DOI":"10.1371\/journal.pmed.1001484","article-title":"Global burden of sickle cell anaemia in children under five, 2010\u20132050: Modelling based on demographics, excess mortality, and interventions","volume":"10","author":"Piel","year":"2013","journal-title":"PLoS Med"},{"key":"R9-20260529","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/bjh.12024","article-title":"High one-year mortality in adults with sickle cell disease and end-stage renal disease","volume":"159","author":"McClellan","year":"2012","journal-title":"Br J Haematol"},{"key":"R10-20260529","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.294.1.81","article-title":"Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease","volume":"294","author":"Morris","year":"2005","journal-title":"JAMA"},{"key":"R11-20260529","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular haemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"key":"R12-20260529","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1681\/ASN.2002010084","article-title":"Glomerular involvement in adults with sickle cell hemoglobinopathies: Prevalence and clinical correlates of progressive renal failure","volume":"17","author":"Guasch","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R13-20260529","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0168-8227(92)90003-A","article-title":"Micral-Test: A qualitative dipstick test for micro-albuminuria","volume":"18","author":"Spooren","year":"1992","journal-title":"Diabetes Res Clin Pract"},{"key":"R15-20260529","doi-asserted-by":"crossref","first-page":"798","DOI":"10.15171\/ijhpm.2018.19","article-title":"Out-of-pocket payments, catastrophic health expenditure and poverty among households in Nigeria","volume":"7","author":"Aregbeshola","year":"2018","journal-title":"Int J Health Policy Manag"},{"key":"R16-20260529","first-page":"e15059","article-title":"All-cause mortality and incidence of major adverse cardiac events in sickle cell nephropathy","volume":"13","author":"Udani","year":"2021","journal-title":"Cureus"},{"key":"R18-20260529","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","article-title":"The nephropathy of sickle cell trait and sickle cell disease","volume":"18","author":"Ataga","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"R19-20260529","first-page":"171","article-title":"Renal disease in adult Nigerians with sickle cell anaemia: Prevalence, clinical features and risk factors","volume":"23","author":"Bolarinwa","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R20-20260529","doi-asserted-by":"crossref","first-page":"247","DOI":"10.9734\/jammr\/2022\/v34i2231600","article-title":"Prevalence and determinants of microalbuminuria in sickle cell disease patients","volume":"34","author":"Odeyemi","year":"2022","journal-title":"J Adv Med Med Res"},{"key":"R21-20260529","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4103\/1596-3519.76578","article-title":"Proteinuria among adult sickle cell anaemia patients in Nigeria","volume":"10","author":"Abdu","year":"2011","journal-title":"Ann Afr Med"},{"key":"R22-20260529","first-page":"c226","article-title":"Kidney dysfunction and risk factors in sickle cell disease","volume":"118","author":"Arogundade","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R23-20260529","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1681\/ASN.2011101019","article-title":"Vasculature and kidney complications in sickle cell disease","volume":"23","author":"Nath","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R24-20260529","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/17474086.2022.2043743","article-title":"Blood pressure variation in sickle cell disease: A systematic review and meta-analysis","volume":"15","author":"Nguweneza","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"R25-20260529","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0002-9343(96)00407-X","article-title":"Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia","volume":"102","author":"Pegelow","year":"1997","journal-title":"Am J Med"},{"key":"R26-20260529","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00151829-200605010-00003","article-title":"New strategies for the treatment of pulmonary hypertension in sickle cell disease: The rationale for arginine therapy","volume":"5","author":"Morris","year":"2006","journal-title":"Treat Respir Med"},{"key":"R27-20260529","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/00043426-200011000-00009","article-title":"Arginine and nitric oxide patterns in sickle cell disease","volume":"22","author":"Morris","year":"2000","journal-title":"J Pediatr Hematol Oncol"},{"key":"R28-20260529","first-page":"167","article-title":"Arginine metabolome and pain in sickle cell disease","volume":"9","author":"Bakshi","year":"2016","journal-title":"J Pain Res"},{"key":"R29-20260529","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1002\/hsr2.1167","article-title":"Effects of L-arginine supplementation in sickle cell disease: Systematic review and meta-analysis","volume":"6","author":"Sadeghi","year":"2023","journal-title":"Health Sci Rep"},{"key":"R30-20260529","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1172\/JCI89741","article-title":"Intravascular haemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Invest"},{"key":"R31-20260529","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassaemia","volume":"2008","author":"Morris","year":"2008","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"R32-20260529","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1182\/asheducation-2008.1.177","article-title":"Mechanisms of vasculopathy in sickle cell disease and thalassaemia","volume":"2008","author":"Morris","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"R33-20260529","first-page":"167","article-title":"The role of the arginine metabolome in pain: Implications for sickle cell disease","volume":"9","author":"Bakshi","year":"2016","journal-title":"J Pain Res"},{"key":"R34-20260529","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1164\/rccm.200208-967OC","article-title":"Arginine therapy: A new treatment for pulmonary hypertension in sickle cell disease?","volume":"168","author":"Morris","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R35-20260529","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood-2005-06-2373","article-title":"Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease","volume":"107","author":"Kato","year":"2006","journal-title":"Blood"},{"key":"R36-20260529","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrneph.2015.8","article-title":"Sickle cell disease: Renal manifestations and mechanisms","volume":"11","author":"Nath","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"R37-20260529","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1681\/ASN.2011101019","article-title":"Vasculature and kidney complications in sickle cell disease","volume":"23","author":"Nath","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R38-20260529","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1002\/hsr2.1167","article-title":"Effects of L-arginine supplementation in patients with sickle cell disease: A systematic review and meta-analysis of clinical trials","volume":"6","author":"Sadeghi","year":"2023","journal-title":"Health Sci Rep"},{"key":"R39-20260529","doi-asserted-by":"crossref","first-page":"15215","DOI":"10.1073\/pnas.221292098","article-title":"Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease","volume":"98","author":"Aslan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R40-20260529","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1080\/17474086.2017.1395279","article-title":"The spectrum of sickle hemoglobin-related nephropathy: From sickle cell disease to sickle trait","volume":"10","author":"Naik","year":"2017","journal-title":"Expert Rev Hematol"},{"key":"R41-20260529","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/pbc.24100","article-title":"Effect of hydroxyurea treatment on renal function parameters: Results from the Multi-Center Study of Hydroxyurea in Children with Sickle Cell Anemia (MSH)","volume":"59","author":"Alvarez","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"R42-20260529","first-page":"282","article-title":"Renal functional decline in sickle cell disease","volume":"76","author":"Nath","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"R43-20260529","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1164\/rccm.202108-1930OC","article-title":"Arginine therapy and cardiopulmonary hemodynamics in hospitalized children with sickle cell anemia: A prospective, double-blinded, randomized placebo-controlled clinical trial","volume":"206","author":"Onalo","year":"2022","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_853_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:21:54Z","timestamp":1787844114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_853_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_853_25","relation":{},"ISSN":["1119-3077","2229-7731"],"issn-type":[{"value":"1119-3077","type":"print"},{"value":"2229-7731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-12-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}